Travson
Travoprost 0.004%
Greater 24-hour IOP reduction efficacy than latanoprost
(Ophthalmology 2008)
Healthcare Professionals login
Travson
Travoprost 0.004%
Greater sterility assurance due to filling inside a barrier isolator
(WHO Good Manufacturing Practices 2011 | Pharmaceutical Manufacturing 2003)
View Research Library
Travson
Travoprost 0.004%
FDA approved sources of API and medical grade plastic
Watch Video
Travson
Travoprost 0.004%
Travoprost Eye Drops in medical-grade PE bottles manufactured inside barrier-isolator.
Each mL of solution contains 40mcg of Travoprost.
Available in a pack of 2.5mL medical-grade PE bottle.
For topical use only.
Product Information
Indications
For reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Contraindications
Hypersensitivity to the active substance or to any of the excipients.
Adverse Effects
Ocular hyperaemia
Iris hyperpigmentation
Dosage
Instil 1 drop in the affected eye(s) once daily in the evening.
Additional Information/ Precautions
Pigmentation of the iris, periorbital tissue (eyelid) and eyelashes can occur.
Gradual change to eyelashes including increased length, thickness and number of lashes which is sually reversible.
Women who are pregnant or attempting to become pregnant should exercise appropriate precautions to avoid direct exposure to the contents of the bottle.
For prescribing information,
Please Click Here
Previous
Next
Zoom In
Zoom Out
100%
Page:
/ 2
Member Log In
×
Mobile Number or Email Address
Receive Link
Not Registered? Please Sign Up
PMDC Number
Full Name
Email Address
Mobile Number
(e.g. 03xxxxxxxxx)
Hospital/Clinic Name & Address
Speciality
--Select--
GP
Consultant
Surgeon
Other
How Did You Hear About Us?
--Select--
Fellow doctor
Our representative
Other
Sign Up